Bull & Bear

Bull and Bear

Verdict: Watchlist — the contract-structure change Bull cites is real, but the entry is at the 95th percentile of the 52-week range immediately after a Q2 print that the forensic record itself flags as embedding non-repeating items, and the decisive evidence sits in a near-term observable (Q3 FY2026 gross margin) that has not yet printed. Bear has the stronger near-term hand: insiders sold $153M (137 discretionary open-market trades, S code) against $7.8M of buying, FY2025 free cash flow of $1.7B does not support an $880B market cap on any historical metric, and industry CY2026 capex above $70B has preceded every memory glut since 2014. Bull has the stronger structural hand: CY2026 HBM is fully pre-sold under multi-year SCAs, 1γ EUV DRAM is the lowest-cost node, and net debt/EBITDA at 0.27x means Micron cannot be forced into a bad print. The single tension that decides the call is whether Q2 FY2026's 75% non-GAAP gross margin was a genuine signal of HBM-driven franchise economics or a one-quarter peak built on the Singapore tax shield, a $2B working-capital lift, and a likely settlement item. A Q3 FY2026 print at 50%+ would corroborate Bull and warrant a position; a print below 45% would corroborate Bear and align with the $450 downside scenario.

Bull Case

No Results

Target: $1,200 over 12–18 months via normalized FY2027 EPS of ~$100 (HBM ramps to ~30% of DRAM revenue, $48B top line, 45% op margin midway between Q1 FY26 and the SK hynix peer ceiling) on a 12× multiple — below MU's trailing 36×, above SK hynix's governance-discounted 7×, inside the 10–15× band cyclical-leader semis trade at when the franchise is intact. Primary catalyst: Q3 FY2026 print (late June 2026) confirming 45–55% gross margin as the sustainable level after stripping Q2 noise, plus first meaningful HBM4 revenue from the NVIDIA Vera Rubin ramp. Disconfirming signal: Q3 FY2026 GM below 45%, or public disclosure that Samsung has displaced Micron HBM4 allocation share at NVIDIA Vera Rubin Ultra. Either single data point breaks the thesis — exit, do not average down. Bull's weakest point — that node-leadership protects through the next trough — was dropped here; it depends on a downturn that the thesis is trying to argue away.

Bear Case

No Results

Downside scenario: $450 over 12–18 months via 10× forward P/E (Micron's own 10-year median) on normalized FY2027 EPS of ~$45 — a 50%+ haircut to consensus FY26 of ~$95 because the consensus number embeds peak-ASP, peak-mix, and peak working-capital benefits that may not survive a 2027 supply normalization; 8× EV/EBITDA on through-cycle EBITDA and P/B compression toward the 2.5× prior-cycle peak both land in the same $400–$500 zone. Primary trigger: First quarterly gross-margin print below 50% — Q2 FY26 non-GAAP GM was 75%, Q1 was 56%; any sequential step-down would force consensus FY27 EPS revisions of $30+ and remove the forward-P/E support defending the $782 print. Days-inventory crossing back above 150 (it was 162 at the FY23 trough) is the parallel observable. Cover signal: HBM4 share at NVIDIA Vera Rubin Ultra (CY2027) locked at 25%+ via signed multi-year SCAs and combined industry CY2027 capex guided below $60B — that combination would mean oligopoly discipline survived peak capex. Bear's weakest point — the 20:1 insider sell-to-buy ratio — was retained inside point 4 of the draft but is not surfaced here as a standalone; insider sales after a 7× rally are partly mechanical 10b5-1 unwinds and do not carry as much weight as the cycle and forensic evidence.

The Real Debate

No Results

Verdict

Watchlist. Bear carries slightly more weight on near-term evidence — the forensic record on the Q2 FY2026 print is explicit that the 75% non-GAAP gross margin embeds non-repeating items, $880B of market cap on $1.7B of trailing free cash flow at the 95th percentile of the 52-week range is the wrong entry geometry, and $153M of discretionary insider sales against $7.8M of buying is one-sided enough to weigh even after discounting for 10b5-1 mechanics. The decisive tension is the Q3 FY2026 gross-margin print: it is the single observable that resolves whether the 75% peak was a contracted-HBM signal or borrowed earnings, and it will print before any reasonable position is stale. Bull could still be right because the contract structure genuinely has changed — CY2026 HBM is pre-sold under multi-year SCAs, 1γ EUV is the lowest-cost node, the balance sheet at 0.27× net debt/EBITDA cannot be broken by one bad quarter, and a peer earning 72% op margin on the same customer and node proves the margin ceiling is real. The verdict would move to Lean Long on a Q3 FY26 print at 50%+ gross margin paired with explicit CY2027 capex guidance below $60B and HBM4 allocation at NVIDIA Vera Rubin Ultra locked above 25%; it would move to Lean Short / Avoid Ownership on a Q3 FY26 print below 45% or a visible Samsung allocation gain on HBM4. Until then, paying 36× trailing earnings into a forensically flagged peak quarter is unattractive enough to wait for the print.